<br data-mce-bogus="1">

To become the “1st line on the table therapy” in treating peripheral vascular occlusions by developing a “versatile” solution aimed at rapid reperfusion without the need for surgery or thrombolytic drug therapies.

ICHOR is a medical device company that has developed a 7F (510k) arterial and a 14F venous percutaneous reperfusion system which offers versatility to treat a wide range of vascular occlusions (2mm – 18mm vessels). “A one size fits all system that replicates successful parameters of surgical clot removal. The technology gives physicians clinical flexibility and incorporates a health economic element that will make ICHOR a 1st line on the table therapy for physicians and hospitals.”